Authors: Sally Arai; Hans-G Klingemann

Source: Expert Opinion on Biological Therapy, Volume 5, Number 2, 1 February 2005 , pp. 163-172(10)

Publisher: Informa Healthcare

Abstract:

As part of the innate immune system, natural killer (NK) cells form the first line of defence against pathogens or transformed/cancerous host cells. Recent experimental and clinical data show the possibility of exploiting NKactivity as a cell-based immunotherapy to treat cancer. This review di-scusses the recent knowledge on NK cell biology that has impacted on its development as a treatment for cancer.

Keywords: cancer; immunotherapy; natural killer cells

Document Type: Review article

DOI: http://dx.doi.org/10.1517/14712598.5.2.163

Publication date: 2005-02-01

More about this publication?

• Editorial Board
• Information for Authors
• Subscribe to this Title
• Terms & Conditions
• ingentaconnect is not responsible for the content or availability of external websites

Related content

• In this: publication
• By this: publisher
• In this Subject: Organic Chemistry ,  Oncology
• By this author: Sally Arai ;  Hans-G Klingemann

Website © Publishing Technology. Article copyright remains with the publisher, society or author(s) as specified within the article.

• Terms and conditions
• Privacy policy
• Information for advertisers